[Use of cholinomimetics in the treatment of endogenous autism in children].

Twenty children with endogenous autism of mild and moderate severity (30-44.5 scores according to the CARS), aged 3-8 years, were treated with choline alfoscerate (CA), 400 mg/day, during 8 weeks in the presence of maintenance therapy with neuroleptics (17 cases). Positive therapeutic effect was observed in 89% of the patients: significant improvement--in 61% and minimal efficacy--in 28%. Statistically significant positive changes in the patient's state were observed in the general improvement of behavior (p<0.001), development of social and communicative skills, as well as self-service, reduction of marked speech disturbances (p<0.001) and motor sphere (p<0.001), enhancement of learning activity and productivity (p<0.05). Good tolerability to the therapy, without patient's state worsening was registered. Some patients exhibited strengthening of affective lability in the first weeks of the treatment which attenuated to the 4th week as the CA dosages decreased to 400 mg every other day. CA may be recommended for combined therapy with neuroleptics as an effective and safe medicine for the treatment of cognitive and behavioral disorders in patients with children's autism.
AuthorsM G Krasnoperova, N V Simashkova, V M Bashina
JournalZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova / Ministerstvo zdravookhraneniia i meditsinskoĭ promyshlennosti Rossiĭskoĭ Federatsii, Vserossiĭskoe obshchestvo nevrologov [i] Vserossiĭskoe obshchestvo psikhiatrov (Zh Nevrol Psikhiatr Im S S Korsakova) Vol. 104 Issue 6 Pg. 35-9 ( 2004) ISSN: 1997-7298 [Print] Russia
Vernacular TitlePrimenenie kholinomimetikov v lechenii éndogennogo detskogo autizma.
PMID15285632 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Antipsychotic Agents
  • Glycerylphosphorylcholine
  • Age Factors
  • Antipsychotic Agents (administration & dosage, therapeutic use)
  • Autistic Disorder (diagnosis, drug therapy)
  • Child
  • Child, Preschool
  • Drug Therapy, Combination
  • Female
  • Glycerylphosphorylcholine (administration & dosage, therapeutic use)
  • Humans
  • Male
  • Sex Factors
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: